Drugs News and Research

RSS

Current advances in nanoparticles and their role as anticancer drug-delivery vectors

Nanotechnology has contributed a great deal to the field of medical science. It has enabled researchers to design tools to deliver drugs to specific targets in a living organism.

4 Jun 2020

Designing a prototype spike protein vaccine for SARS-CoV-2

A recent study published on the preprint server bioRxiv in June 2020 reports the development of a prototype vaccine containing multiple antigenic sites, based on the spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is causing the current COVID-19 pandemic. If successful, this could lead to the development of an effective, non-allergenic vaccine that induces both humoral and cellular immunity.

4 Jun 2020

Alpaca-derived antiviral agent neutralizes SARS-CoV-2

Researchers at Karolinska University Hospital and the University of Cape Town have identified an antibody fragment that targets the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein and potently neutralizes the virus.

4 Jun 2020

Using supercomputers to knock out drug side effects

Psychedelic drugs could be effective in treating psychiatric disorders such as depression and post-traumatic stress disorder, but medical use of these drugs is limited by the hallucinations they cause.

4 Jun 2020

New technology to monitor anti-drug antibodies in MS patients may have potential for COVID-19 testing

A new study led by Queen Mary University of London has demonstrated the effectiveness of using a novel light technology to monitor the presence of anti-drug antibodies in the treatment of multiple sclerosis, which can lead to drug resistance and treatment failure.

4 Jun 2020

Natural molecules that stimulate dopamine production may help reverse Parkinson's disease

Investigators have identified two molecules naturally produced by the body that stimulate the production of dopamine, the molecule that is in short supply in the brains of patients with Parkinson's disease.

4 Jun 2020

JGU professor wins Exploration Grant for research into membrane proteins of parasites

So-called neglected tropical diseases (NTDs) cause great suffering in some of the world's poorest countries and can lead also to significant economic losses due to, for example, the infestation of animal herds.

4 Jun 2020

New risk genes for problematic alcohol use discovered

Do you have what is known as problematic alcohol use? Then statistically you will also be particularly genetically predisposed to develop e.g. depression and insomnia. And to become dependent on drugs and tobacco. This is shown by a new international study in which researchers from iPSYCH are involved.

4 Jun 2020

New treatments for sleep apnea and other weak muscle conditions to be unveiled at global biotech event

A world-first therapeutic for treating sleep apnea and a range of other weak muscle conditions will be unveiled at global biotech innovation event, Bio Digital (June 8-12).

4 Jun 2020

New therapeutic strategies for treating lung cancer

The international study "Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures", recently published in the scientific journal Nature Communication, has taken a further step in the development of new therapeutic strategies to treat lung cancer.

4 Jun 2020

Nicotine promotes spread of lung cancer cells into the brain, study finds

Researchers at Wake Forest School of Medicine have discovered that nicotine promotes the spread of lung cancer cells into the brain, where they can form deadly metastatic tumors.

4 Jun 2020

Small protein has a large impact on bacterial gene regulation

Meningococci are bacteria that can cause life-threatening meningitis and sepsis. These pathogens use a small protein with a large impact: The RNA-binding protein ProQ is involved in the activation of more than 250 bacterial genes.

4 Jun 2020

New platform can speed up the development of novel antibiotics

Harmful bacteria react less and less to common antibiotics. The infections they cause are therefore increasingly deadly.

4 Jun 2020

Biorelate offers free access to AI-based drug discovery tool: Galactic

Biorelate, a UK-based AI start up, is offering all researchers free use of Galactic, its cloud-based web tool, to support biomedical research while lab access is restricted around the world.

From Biorelate Ltd 4 Jun 2020

In hard-hit areas, COVID’s ripple effects strain mental health care systems

In late March, Marcell's girlfriend took him to the emergency room at Henry Ford Wyandotte Hospital, about 11 miles south of Detroit.

4 Jun 2020

Protein markers could help predict how ill a COVID-19 patient will become

Researchers at the Francis Crick Institute and Charité – Universitätsmedizin Berlin have identified 27 protein biomarkers that could be used to predict whether a patient with COVID-19 is likely to become severely ill with the disease.

4 Jun 2020

27 protein biomarkers predict COVID-19 severity in patients

Some patients infected with the novel coronavirus may experience only mild symptoms, while others may need medical care due to severe illness. People who are at a high risk of developing severe coronavirus disease (COVID-19) include older adults and those with underlying health conditions. However, severe disease has also been seen in young people with no underlying disease.

4 Jun 2020

New consensus on how cancer clinical trial stakeholders can best interact on social platforms

Social media is an integral part of medicine and an increasingly important conduit for sharing information about clinical trials.

4 Jun 2020

Distancing, masks and eye gear protects against spread of SARS-CoV-2 finds large study

In a comprehensive systemic analysis of different studies, researchers have found that physical distancing, use of face masks, and eye protection were the most effective ways to prevent the spread of SARS-CoV-2 infection from one person to another.

4 Jun 2020

Avoiding 'air hunger' and psychological trauma in COVID-19 ARDS survivors

A new paper published online in the Annals of the American Thoracic Society examines ventilation and medication strategies that can help avoid psychological trauma for severe COVID-19 survivors treated for acute respiratory distress syndrome with mechanical ventilation.

4 Jun 2020